Literature DB >> 12904709

Superficial vein thrombosis: risk factors, diagnosis, and treatment.

Herve Decousus1, Magali Epinat, Karine Guillot, Sara Quenet, Christian Boissier, Bernard Tardy.   

Abstract

Superficial vein thrombosis (SVT) risk factors are close to those of venous thromboembolism (VTE). Diagnosis is made in a clinical setting but ultrasonography is useful to eliminate concomitant deep vein thrombosis (DVT). For SVT of the lower limbs, which is the main location, varicose veins represent the principal cause but underlying conditions (e.g.: autoimmune diseases, malignancy or thrombophilia) must be sought in idiopathic, migrant or recurrent SVT and in the absence of varicose veins. Concomitant DVT and pulmonary embolism can occur in approximately 15% and 5% respectively. Historical treatments consist of anti-inflammatory agents plus elastic stockings and, in case of varicose veins, thrombectomy and stripping. Other treatments (anticoagulants, vein ligation) were assessed to limit the VTE risk. A one-month prophylactic dose of low molecular weight heparin plus elastic stockings could be the appropriate strategy in most cases. Other studies are needed before definitive conclusions can be drawn.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12904709     DOI: 10.1097/00063198-200309000-00009

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  13 in total

1.  [Extensive pulmonary embolism secondary to varicophlebitis].

Authors:  C Sieblist; G Wienrich; M P Schön; M Zutt
Journal:  Hautarzt       Date:  2010-11       Impact factor: 0.751

2.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Increase in venous complications associated with etomidate use during a propofol shortage: an example of clinically important adverse effects related to drug substitution.

Authors:  Logan Kosarek; Stuart R Hart; Lucy Schultz; Neil Digiovanni
Journal:  Ochsner J       Date:  2011

Review 4.  Controversies in venous thromboembolism: to treat or not to treat superficial vein thrombosis.

Authors:  Jan Beyer-Westendorf
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

5.  Great saphenous vein thrombosis causing acute pulmonary embolism suggested by combined CT venography and pulmonary angiography.

Authors:  En Haw Wu; Chung Kong; I Chang Hsieh; Li Chang Lien
Journal:  Emerg Radiol       Date:  2007-12-11

6.  Superficial venous thrombosis of the upper limb presenting to a chiropractic clinic: a case report.

Authors:  Paul Mastragostino; Chadwick Chung
Journal:  J Can Chiropr Assoc       Date:  2020-04

Review 7.  Superficial venous thrombosis: disease progression and evolving treatment approaches.

Authors:  Maria E Litzendorf; Bhagwan Satiani
Journal:  Vasc Health Risk Manag       Date:  2011-08-31

8.  Oral Thrombus: Report of 122 cases with clinically descriptive data.

Authors:  P-L Tobouti; F-M Pigatti; M-C Martins-Mussi; S-C-O Machado de Sousa
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2017-05-01

Review 9.  Unmet Needs in Anticoagulant Therapy: Potential Role of Rivaroxaban.

Authors:  John W Eikelboom; Stuart J Connolly
Journal:  Cardiol Res       Date:  2015-06-11

10.  Treatment of iatrogenic IVC occlusion with implantation of a stent of a new shape dedicated to aortic aneurysms.

Authors:  Dominik Sieroń; Phillip Wiggermann; Daniel Knap; Ivan Platzek; Wojciech Wawrzynek; Christian Stroszczynski
Journal:  Pol J Radiol       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.